Search


	Podcast:		The Bio Report
	Episode:		Restoring the Guardian of the Genome to Fight Tumors
	Category:		Business
	Duration:		00:20:26
	Publish Date:		2021-12-23 09:00:26
	Description:		The p53 protein is known as the “guardian of the genome.” It plays an essential role in suppressing tumors. Rain Therapeutics is targeting a regulator of p53 that is overexpressed in certain cancer and can inactivate it, allowing certain cancers to grow and progress. We spoke to Avanish Vellanki, chairman and CEO of Rain Therapeutics, about the company’s experimental precision therapy milademetan, how it works, and its potential to treat a range of cancers.
	Total Play:		0

Some more Podcasts by Levine Media Group

600+ Episodes

The Bio Repo ..